198 related articles for article (PubMed ID: 9661170)
21. Research interactions between industry and academia: a corporate perspective.
Citron P
Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
[No Abstract] [Full Text] [Related]
22. OECD says industrial biotech not realizing potential.
Niiler E
Nat Biotechnol; 2001 Jun; 19(6):493-4. PubMed ID: 11385413
[No Abstract] [Full Text] [Related]
23. Materials exchange deal meager boost to India's biotech.
Jayaraman KS
Nat Biotechnol; 2005 Sep; 23(9):1031. PubMed ID: 16151380
[No Abstract] [Full Text] [Related]
24. New Zealand launches biotech seed fund.
Griggs K
Nat Biotechnol; 2004 Apr; 22(4):480-1. PubMed ID: 15085809
[No Abstract] [Full Text] [Related]
25. Transferring EU-funded biotechnology research to European bioindustry.
Lawler C; van der Meer R; Viseur J
Nat Biotechnol; 1998 Jun; 16(6):494. PubMed ID: 9624665
[No Abstract] [Full Text] [Related]
26. Regional Development 1996. The Caledonian way.
Quinn N
Nat Biotechnol; 1996 Aug; 14(8):962-3. PubMed ID: 9660658
[No Abstract] [Full Text] [Related]
27. Is the university-industrial complex out of control?
Nature; 2001 Jan; 409(6817):119. PubMed ID: 11196604
[No Abstract] [Full Text] [Related]
28. Parascientific education for PhDs.
Persidis A; Dunn WE; MacMillan IC
Nat Biotechnol; 1996 Apr; 14(4):406-8. PubMed ID: 9630907
[No Abstract] [Full Text] [Related]
29. Biotech gap between North and South.
Huete-Pérez JA; Orozco DA
Science; 2001 Dec; 294(5550):2289-90. PubMed ID: 11764811
[No Abstract] [Full Text] [Related]
30. Singapore and the Nanyang Technological University--A young country with a young university on the move.
Andersson B; Mayer T
Biointerphases; 2010 Sep; 5(3):FA9-14. PubMed ID: 21171719
[No Abstract] [Full Text] [Related]
31. The National University of Singapore and what it does.
Halliwell B
Biointerphases; 2010 Sep; 5(3):FA15-8. PubMed ID: 21171707
[No Abstract] [Full Text] [Related]
32. Case study: India's billion dollar biotech.
Chakma J; Masum H; Perampaladas K; Heys J; Singer PA
Nat Biotechnol; 2010 Aug; 28(8):783. PubMed ID: 20697399
[No Abstract] [Full Text] [Related]
33. Bayh-Dole: if we knew then what we know now.
Boettiger S; Bennett AB
Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
[No Abstract] [Full Text] [Related]
34. Calling for entrepreneurs: London.
Smaglik P
Nat Biotechnol; 2002 Dec; 20(12):1281-2. PubMed ID: 12454679
[No Abstract] [Full Text] [Related]
35. The biotechnology industry: What's next?
Guertin PA
Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
[No Abstract] [Full Text] [Related]
36. International technology transfer to China: the case of biotechnology.
Ding HB
Issues Stud; 2000; 36(2):133-54. PubMed ID: 18354856
[No Abstract] [Full Text] [Related]
37. Baywatch: San Francisco.
Smaglik P
Nature; 2004 Feb; 427(6975):658-9. PubMed ID: 14961125
[No Abstract] [Full Text] [Related]
38. Ontario.
Hoag H
Nature; 2005 Mar; 434(7033):676-7. PubMed ID: 15800632
[No Abstract] [Full Text] [Related]
39. BTJ Forum: Biotech in the financial crisis.
Biotechnol J; 2009 Aug; 4(8):1108-10. PubMed ID: 19685461
[No Abstract] [Full Text] [Related]
40. Business: stepping out.
Dalton R
Nature; 2008 Mar; 452(7184):146. PubMed ID: 18337794
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
